Advertisement

Pasireotide/pegvisomant

Diabetes: case report

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Alexandraki KI, et al. Role of receptor profiling for personalized therapy in a patient with a growth hormone-secreting macroadenoma resistant to first-generation somatostatin analogues. Journal of Personalized Medicine 9: No. 4, 2019. Available from: URL: http://doi.org/10.3390/jpm9040048

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Pasireotide/pegvisomant. Reactions Weekly 1786, 133 (2020). https://doi.org/10.1007/s40278-020-73607-4

    Download citation